Aktis Oncology Statistics

NASDAQ: AKTSHealth CareBiotechnology: Pharmaceutical PreparationsUSD

18.00+0.14 (+0.78%)

At close: Oct 7, 4:00 PM ET · Delayed 15 min

Aktis Oncology by the numbers

Aktis Oncology has a market capitalization of $1.00 billion based on 53.75M shares outstanding. With trailing EPS of $-1.70, Aktis Oncology is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 22.2% below its 50-day average and 16.1% below its 200-day average.

Average daily trading volume is 365.15K shares, or about $6.6 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

AKTS valuation vs. peer median

AKTS compared with the median of 8 peer companies
Metric	AKTS	Peer median	Difference
Market cap	$1.00B	$981.22M	+2%
Avg. volume	365.15K	1.01M	-64%

Peer median across 8 companies: SVRA, PCRX, SPTX, LTGO, OPK, KURA, ANRO, MLTX.

Valuation

Market cap: $1.00B
P/E (TTM): —
Forward P/E: —
EPS (TTM): $-1.70
Shares outstanding: 53.75M

Price and trading

Previous close: 17.86
Open: 17.72
Day range: 17.72 – 18.35
52-week range: 14.72 – 34.19
50-day moving average: 23.15
200-day moving average: 21.46
Beta: —
Volume: 294.10K
Average volume: 365.15K

Dividends and events

Annual dividend: None
Dividend yield: —
Ex-dividend date: —
Next earnings date: Nov 12, 2026

Additional statistics

Market Cap: 1.00B
Forward Pe: -8.38
Eps: -1.70
Dividend Yield: 0.00%
Dividend Rate: 0.00
Week52 High: 34.19
Week52 Low: 14.72
Avg Volume: 365.15K
Shares Outstanding: 53.75M
Ma50: 23.15
Ma200: 21.46
Earnings Date: Nov 12, 2026
Pct From52w High: -47.35%
Pct From52w Low: 22.28%